BioSpace News Archive

Biotech firm Rubix LS announces critical milestone achievement for their lead combination device that halted the progression of osteonecrotic disease in 98% of participants.

1933 Industries Inc. (the “Company” or “1933 Industries”) (CSE: TGIF) (OTCQX: TGIFF) a licensed cultivator and producer of cannabis flower and concentrates and manufacturer of hemp/CBD products in Nevada, Colorado and California, announced today that the financial results for the first quarter ending October 31, 2018 will be released on December 20, 2018, after market close.

Siren, the health technology company that developed Neurofabric™, a machine-washable, machine-dryable smart textile with built-in sensors, today announced publication of a foundational paper supporting its approach in Journal of Medical Internet Research (JMIR), the leading peer-reviewed journal for digital medicine, and health & healthcare in the Internet age

Council to increase doctor and medical voices into RealSelf operations, products and features and further help consumers make confident aesthetic decisions

Today Lexogen launches a Version 2 (V2) upgrade for the TeloPrime Full-Length cDNA Amplification Kit; an all-in-one protocol for generating 5' cap-specific full-length cDNA from as little as 1 ng of total RNA.

Available in the mobile App and in an abridged format for primary care providers, key Standards of Care updates include new treatment decision pathways, options to decrease cardiovascular disease risk, and a new section on the use of technology

ConvaTec Group Plc (“ConvaTec”), a leading global medical products and technologies company, welcomes the UK Government’s support for the wound care industry as part of its Life Sciences Sector Deal, and is pleased to set out its commitment to supporting the Government on the objectives it outlined.

On behalf of the Honourable Ginette Petitpas Taylor, federal Minister of Health, the Honourable Larry Bagnell, Member of Parliament, and the Honourable Pauline Frost, Minister of Health and Social Services, Yukon, will announce new measures to increase access to treatment for substance use disorder.

Garden Remedies, Inc., Massachusetts’ only cannabis company founded and led by a woman physician, confirms a significant expansion of its business in 2018.

Amgen (NASDAQ:AMGN) today announced the submission of a Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for ABP 710, a biosimilar candidate to REMICADE® (infliximab).